What is topical finasteride, and how is it used for hair loss in Europe?

Topical finasteride explained: androgenetic alopecia, DHT reduction, scalp application, systemic absorption, and prescribing criteria.

In this episode, we outline how topical finasteride works for male pattern hair loss and how doctors assess suitability under EU medical guidance.

You’ll learn:

• What androgenetic alopecia is (genetic hair thinning linked to dihydrotestosterone, DHT)

• How finasteride reduces DHT levels in the scalp

• The difference between oral and topical formulations

• Evidence on systemic absorption and side effect profile

• When combination therapy (e.g., with minoxidil) may be considered

• Potential risks, including sexual side effects

• Situations where treatment requests may be declined pending full assessment

We explain how doctors assess hair loss pattern, duration, family history, age, medical history, fertility plans, and contraindications during an online consultation in the EU. Finasteride is not suitable for everyone and requires informed medical review.

This episode reflects the clinical standards used by Mobi Doctor, where hair loss consultations are reviewed by a registered physician in line with EU prescribing guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/topical-finasteride